Lupin - Quaterly Results

18 May 2022 Evaluate
A fair growth of 13.49% in the revenue at Rs. 28553.90 millions was reported in the March 2022 quarter as compared to Rs. 25159.60 millions during year-ago period.The Net Loss for the quarter ended March 2022 is Rs. -358.90 millions as compared to Net Profit of Rs. 3163.60 millions of corresponding quarter ended March 2021The company reported a good operating profit of 5171.50 millions compared to 4911.20 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 28553.90 25159.60 13.49 117716.70 110559.30 6.47 117716.70 110559.30 6.47
Other Income 570.30 660.70 -13.68 2169.90 1290.90 68.09 2169.90 1290.90 68.09
PBIDT 5171.50 4911.20 5.30 4261.30 21731.50 -80.39 4261.30 21731.50 -80.39
Interest 245.80 123.10 99.68 734.70 406.20 80.87 734.70 406.20 80.87
PBDT 4925.70 4788.10 2.87 3526.60 21325.30 -83.46 3526.60 21325.30 -83.46
Depreciation 1310.20 1250.10 4.81 5141.90 5028.30 2.26 5141.90 5028.30 2.26
PBT 3615.50 3538.00 2.19 -1615.30 16297.00 -109.91 -1615.30 16297.00 -109.91
TAX 3974.40 374.40 961.54 271.70 3710.80 -92.68 271.70 3710.80 -92.68
Deferred Tax 3419.40 236.70 1344.61 -306.30 82.30 -472.17 -306.30 82.30 -472.17
PAT -358.90 3163.60 -111.34 -1887.00 12586.20 -114.99 -1887.00 12586.20 -114.99
Equity 909.00 907.40 0.18 909.00 907.40 0.18 909.00 907.40 0.18
PBIDTM(%) 18.11 19.52 -7.22 3.62 19.66 -81.58 3.62 19.66 -81.58

Lupin Share Price

2176.25 -18.75 (-0.85%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×